Jonathan Yong
Stock Analyst at UBS
(2.63)
# 2,015
Out of 4,873 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $4.34 | +61.29% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $2.84 | +40.85% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $20.02 | +14.89% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $21.75 | +14.94% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.35 | +164.32% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.51 | +26.18% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $5.07 | +57.79% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.16 | +97.57% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $42.95 | -67.40% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $72.68 | +32.09% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $15.09 | +112.06% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $21.70 | +383.87% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $120.92 | -33.84% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $262.53 | -12.01% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $97.65 | +3.43% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $8.00 | +237.50% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $164.21 | -39.10% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $720.82 | -37.57% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $4.00 | +200.00% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.29 | +860.22% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.52 | +17.08% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $294.51 | +18.84% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $21.52 | +341.45% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.80 | +46.55% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $22.00 | +86.36% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $7.48 | +127.27% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.39 | +150.74% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.60 | +6.78% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $179.90 | -18.84% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $54.05 | +96.11% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $175.20 | -10.39% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $316.83 | +16.15% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $238.79 | +165.92% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $67.58 | +73.13% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $13.43 | +123.38% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $379.02 | -21.38% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $171.52 | -44.61% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $305.62 | +61.97% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $4.34
Upside: +61.29%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $2.84
Upside: +40.85%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $20.02
Upside: +14.89%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $21.75
Upside: +14.94%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.35
Upside: +164.32%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.51
Upside: +26.18%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $5.07
Upside: +57.79%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.16
Upside: +97.57%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $42.95
Upside: -67.40%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $72.68
Upside: +32.09%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.09
Upside: +112.06%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $21.70
Upside: +383.87%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $120.92
Upside: -33.84%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $262.53
Upside: -12.01%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $97.65
Upside: +3.43%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $8.00
Upside: +237.50%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $164.21
Upside: -39.10%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $720.82
Upside: -37.57%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $4.00
Upside: +200.00%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.29
Upside: +860.22%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.52
Upside: +17.08%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $294.51
Upside: +18.84%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $21.52
Upside: +341.45%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.80
Upside: +46.55%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.00
Upside: +86.36%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $7.48
Upside: +127.27%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.39
Upside: +150.74%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.60
Upside: +6.78%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $179.90
Upside: -18.84%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $54.05
Upside: +96.11%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $175.20
Upside: -10.39%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $316.83
Upside: +16.15%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $238.79
Upside: +165.92%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $67.58
Upside: +73.13%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $13.43
Upside: +123.38%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $379.02
Upside: -21.38%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $171.52
Upside: -44.61%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $305.62
Upside: +61.97%